Home / Inspections / 1205335

FDA Inspection 1205335 — Medix Biochemica USA, Inc.

Medix Biochemica USA, Inc. — FEI 3004343130

The FDA completed an inspection of Medix Biochemica USA, Inc. on May 3, 2023 in Maryland Heights, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 3, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Maryland Heights, MO (United States)

Facility

Other inspections at this facility

  • 1040189 (NAI Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797510 (NAI Wed Sep 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources